Cardiovascular Disease Online Series: From Prevention to Intervention (Multiple Modules)

Implement practical approaches to common and important cardiometabolic challenges utilizing the latest evidence-based screening guidelines and treatment approaches to achieve reduction of cardiovascular disease risk.

Course Topics and Faculty - Select topic below for additional details and to enroll.

 

 

Credits

Effective Medication Management in Older Adults
Rhonda Cooper-DeHoff, Pharm.D., M.S., FAHA, FACC, FCCP
 0.50
Exercise Prescription for Primary and Secondary Prevention
Michael J. Blaha, M.D., MPH
 0.50
Familial Hypercholesterolemia: Clinical Update*
Paul E. Ziajka, M.D., Ph.D., FNL 
 0.75
Fructose and Metabolic Syndrome: Is There a Link?
Robert H. Lustig, M.D.
 1.0
Metabolic Syndrome: Prevention and Management Strategies 
Roger Blumenthal, M.D. 
 0.75
Obesity: Beyond Lifestyle and Bariatric Surgery
Theodore Feldman, M.D.
 0.50
Practical Medicine: Cardiometabolic Disease
Round Table Discussions - Interview With the Experts Including Practical Tips for the Busy Practitioner
Christie M. Ballantyne, M.D., Michael J. Blaha, M.D., Roger Blumenthal, M.D., Theodore Feldman, M.D. and Michael Ozner, M.D.
 1.75
Resistant Hypertension: Management Strategies*
William C. Cushman, M.D. 
 0.75  0.75  0.75
*Indicates course approved for American Board of Internal Medicine
Maintenance of Certification credits
.
 

 

Target Audience

Cardiovascular Disease Prevention Specialists, Lipidologists, Cardiologists, Family Medicine Physicians, General Internists, Endocrinologists, Gynecologists, Nurses, Nursing Practitioners and Physician Assistants.

Course summary
Course opens: 
03/15/2018
Course expires: 
03/31/2025

See individual course pages for faculty titles and disclosure information. 

PLANNERS - 2018 Cardiometabolic Symposium 

Theodore Feldman, M.D., symposium director, has disclosed that he is a member of the speaker’s bureau for Amgen, Boehringer Ingelheim Pharmaceuticals, Novartis Pharmaceuticals, NovoNordisk and Regeneron/Sanofi, and that he serves as a consultant to Merck. Dr. Feldman has indicated that his presentation will not include discussion of off-label or unapproved usage.

Khurram Nasir, M.D., symposium director, has disclosed that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and they will not include off-label or unapproved product usage in their presentations or discussions.

Michael D. Ozner, M.D., FACC, FAHA has disclosed that he is a member of the scientific advisory board for the Life Extension Foundation, and Author of the books The Great American Heart Hoax, Heart Attack Proof, and The Complete Mediterranean Diet. Dr. Ozner has indicated that his presentation will not include discussion of off-label or unapproved usage.

All other non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer.

See individual module pages for applicable credits and accreditations. 

Please login or register to take this course.